Xiaoyuan (Shawn) Chen, Ph.D.
Chief, Laboratory of Molecular Imaging and Nanomedicine
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health*
Bethesda, MD, USA
Dr. Xiaoyuan (Shawn) Chen received his PhD in Chemistry from the University of Idaho (1999). After two postdocs at Syracuse University and Washington University in St. Louis, he started his Assistant Professorship in 2002 and then moved to Stanford in 2004. He was promoted to Associate Professor in 2008. He moved to NIH in 2009 and became a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. His current research interests include development of molecular imaging toolbox for better understanding of biology, early diagnosis of disease, monitoring therapy response, and guiding drug discovery/development. His lab puts special emphasis on high-sensitivity nanosensors for biomarker detection and theranostic nanomedicine for imaging, gene and drug delivery, and monitoring of treatment. Dr. Chen has published over 800 peer-reviewed papers (H-index > 140, total citations > 72,000 based on google scholar) and numerous books and book chapters. He is the founding editor of journal “Theranostics” (2018 IF = 8.063). He was elected as AIMBE Fellow (2017) and SNMMI Fellow (2020), received SNMMI Michael J. Welch Award (2019), ACS Bioconjugate Chemistry Lecturer Award (2016), NIH Director’s Award (2014), NIBIB Mentor Award (2012). He is also the Past President of Chinese-American Society of Nuclear Medicine and Molecular Imaging (CASNMMI), Past President of the Radiopharmaceutical Science Council (RPSC), Society of Nuclear Medicine and Molecular Imaging (SNMMI), and Past President of the Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN).
* Dr. Chen is serving in his personal capacity and does not represent the NIH nor the Federal Government.
Updated on 2020-04-29.